OMNY Health unveils AI data platform for health tech companies

OMNY Health, a company specializing in monetizing hospital operational data, has introduced an AI-powered platform for health technology companies. This platform provides access to data on more than 75 million patients. The first two companies to utilize this data are QuantHealth, an AI-enabled clinical trial design company, and ArisGlobal, a life sciences company. Both companies aim to leverage this data to enhance their clinical research capabilities.

QuantHealth plans to integrate OMNY's data with its AI technology, already trained on a dataset of 350 million patients. This partnership is expected to accelerate drug development for QuantHealth's pharmaceutical partners by enabling simulated clinical trials. The collaboration aims to predict clinical trial outcomes, patient responses, and drug efficacy more accurately, thereby speeding up the entire process.

ArisGlobal, which focuses on drug development, safety monitoring, and clinical research, will use OMNY's technology to mitigate trial risks and identify patient populations that are more likely to respond to treatments. The company currently offers LifeSphere, a research and development software platform for life sciences.

OMNY Health's CEO, Mitesh Rao, emphasized that their mission is to break down data silos, enabling data to be shared and analyzed to create life-saving treatments and better patient care. He highlighted that partnering with AI developers and providing them with data and tools can accelerate the development of breakthrough therapies and ensure patient safety.

Click here to read the original news story.